5L4-22568-91592

2 vaccinations 5 coded responses 27 check-ins 5 free-text entries 2 call cases

Sex: Female
Age at first dose: 46-50
ZIP prefix: 836 / ID
Registered: 2021-08-04

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-08-04
Registered in v-safe
2021-08-04
Dose 1 — Pfizer-BioNTech
2021-08-05
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain

Adult check-in
2021-08-06
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain

Adult check-in
2021-08-08
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-08-09
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-08-10
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain

Adult check-in
2021-08-11
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-08-18
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-08-27
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-09-05
Health check-in — day 28, dose 1
Feeling: Good

Adult check-in
2021-09-08
Health check-in — day 35, dose 1
Feeling: Good

Adult check-in
2021-09-15
Health check-in — day 42, dose 1
Feeling: Good

Adult check-in
2021-11-03
Dose 2 — Pfizer-BioNTech
2021-11-03
Health check-in — 3 months, dose 1
Feeling: Poor

Adult check-in
2021-11-03
Health check-in — day 0, dose 2
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Nausea, Diarrhea, Abdominal pain

Adult check-in
2021-11-04
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2021-11-05
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2021-11-06
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-11-07
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Muscle or body aches

Adult check-in
2021-11-09
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-11-11
Health check-in — day 7, dose 2
Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-11-17
Survey response — day 14, dose 2
MedDRA: Ageusia, Cough — Feeling: Poor · Be unable to do your normal daily activities

Free text: No taste cough

MedDRA releases: 2024-11 · check-in free text available
2021-11-24
Survey response — day 21, dose 2
MedDRA: Cough, Vision blurred — Feeling: Fair · Be unable to do your normal daily activities

Free text: Caugh n blurry vision

MedDRA releases: 2024-11 · check-in free text available
2021-12-01
Health check-in — day 28, dose 2
Feeling: Fair

Adult check-in
2021-12-08
Health check-in — day 35, dose 2
Feeling: Fair

Adult check-in
2021-12-15
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2022-02-02
Survey response — 3 months, dose 2
MedDRA: Pneumonia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Pneumonia

MedDRA releases: 2024-11 · check-in free text available
2022-02-02
Report sent to call center — 3 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-02-04
Call 1 — Left Voicemail
2022-05-09
Survey response — 6 months, dose 2
MedDRA: SARS-CoV-2 test positive — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Tested positive for Covid

MedDRA releases: 2024-11 · check-in free text available
2022-11-05
Survey response — 12 months, dose 2
MedDRA: Lung disorder — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Constant lung problems

MedDRA releases: 2024-11 · check-in free text available
2022-11-05
Report sent to call center — 12 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-11-07
Call 2 — Left Voicemail
2022-11-07
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-08-04	Pfizer-BioNTech	No
2	2021-11-03	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-02-02	Unsuccessful
2022-11-05	Unsuccessful

Free text

Release 10 — day 14, dose 2

2021-11-17

Symptoms: No taste cough

Release 10 — day 21, dose 2

2021-11-24

Symptoms: Caugh n blurry vision

Release 11 — 3 months, dose 2

2022-02-02

Symptoms: Pneumonia

Release 11 — 6 months, dose 2

2022-05-09

Symptoms: Tested positive for Covid

Release 12 — 12 months, dose 2

2022-11-05

Symptoms: Constant lung problems

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Ageusia	·	·	✓
SD	Cough	·	·	✓
SD	Lung disorder	·	·	✓
SD	Pneumonia	·	·	✓
SD	SARS-CoV-2 test positive	·	·	✓
SD	Vision blurred	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release